Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

JUXTAPID vs KETOPROFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

JUXTAPID vs KETOPROFEN: Safety Overview

Metric JUXTAPID KETOPROFEN
Total FAERS Reports 179 5,550
Deaths Reported 2 393
Death Rate 1.1% 7.1%
Hospitalizations 13 2,947
Average Patient Age 58.0 yrs 47.9 yrs
% Female Patients N/A 61.9%
FDA Approval Date N/A Dec 10, 1997
Manufacturer N/A Allegis Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued